Your browser doesn't support javascript.
loading
Cryo-surgery for symptomatic extra-abdominal desmoids. A proof of concept study.
Efrima, Ben; Ovadia, Joshua; Drukman, Ido; Khoury, Amal; Rath, Ehud; Dadia, Solomon; Gortzak, Yair; Albagli, Assaf; Sternheim, Amir; Segal, Ortal.
  • Efrima B; Division of Orthopaedic Surgery, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Ovadia J; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Drukman I; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Khoury A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rath E; Division of Radiology, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Dadia S; Division of Orthopaedic Surgery, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Gortzak Y; Division of Orthopaedic Surgery, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Albagli A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Sternheim A; Division of Orthopaedic Surgery, Tel Aviv Medical Center, Tel Aviv, Israel.
  • Segal O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Surg Oncol ; 124(4): 627-634, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34043245
BACKGROUND AND OBJECTIVE: Extra abdominal desmoid tumors are rare, highly aggressive, and invasive benign soft tissue tumors. Current treatment modalities show high levels of recurrence and comorbidities. Cryo-surgery as an alternative was subsequently investigated. METHODS: In this retrospective, single center study 11 patients showing symptomatic tumors were treated with individualized cryo-surgery. Treatment protocol included preoperative planning using computer rendered 3D models, intraoperative navigation and execution using cone beam guidance, and postoperative magnetic resonance imaging image analysis using a gaussian mixture model software. Subjective outcomes were reported using Short Form Health Survey (SF-36) questionnaires. RESULTS: Sixteen ablations were performed, each demonstrating a complete match with the determined preoperative plan and model. A total of 9/11 (82%) of patients showed improvements in symptoms and a reduction in tumor volume while 2/11 (18%) did not. Average reduction in tumor volume and viable segments were 36.7% (p = 0.0397) and 63.3% (p = 0.0477), respectively. Mild complications according to the SIR Adverse Event Classification Guidelines were experienced in 3/16 (19%) ablations. SF-36 scores showed a statistically significant improvement (p = 0.0194) in the mental health category and a nonsignificant (p = 0.8071) improvement in the physical health category. CONCLUSION: Cryo-surgery using the three-phase protocol as described may improve the overall outcome of future ablation procedures.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibromatosis Agresiva / Criocirugía / Carga Tumoral Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibromatosis Agresiva / Criocirugía / Carga Tumoral Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Qualitative_research Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article